LANTHEUS HOLDINGS INC (LNTH)
US5165441032 - Common Stock
Why Lantheus Holdings Stock Won Big on Wednesday
Lantheus Announces Share Repurchase Program
Lantheus Announces Share Repurchase Program
BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading...
Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus to Present at the Jefferies London Healthcare Conference
BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...
NASDAQ:LNTH stands out as a stock that provides good value for the fundamentals it showcases.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying.
LNTH Makes Notable Cross Below Critical Moving Average
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
BEDFORD, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading...
Oversold Conditions For Lantheus Holdings (LNTH)
Lantheus Reports Third Quarter 2024 Financial Results
Lantheus Reports Third Quarter 2024 Financial Results
Worldwide revenue of $378.7 million, an increase of 18.4% from third quarter 2023GAAP fully diluted earnings per share of $1.79, compared to $1.88 in the...
Despite its growth, NASDAQ:LNTH remains within the realm of affordability.
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
BEDFORD, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...
Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time
Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time
BEDFORD, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
/PRNewswire/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years....
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Response Rate was 38.1% vs. 12.0%...
Lantheus Appoints Julie Eastland as New Board Member
Lantheus Appoints Julie Eastland as New Board Member
BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...
Bargain Hunting for Stocks: 2 Stocks to Buy in September
Even with the market near all-time highs, there are bargains to be found.
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
BEDFORD, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...